Resveratrol and endothelial function: A literature review

Negin Parsamanesh, Arghavan Asghari, Saeed Sardari, Aida Tasbandi, Tannaz Jamialahmadi, Suowen Xu, Amirhossein Sahebkar

Research output: Contribution to journalReview articlepeer-review

28 Citations (Scopus)


Endothelial dysfunction is a major contributing factor to diseases such as atherosclerosis, diabetes mellitus, obesity, hypertension, acute lung injury, preeclampsia, among others. Resveratrol (RSV) is a naturally occurring bioactive polyphenol found in grapes and red wine. According to experimental studies, RSV modulates several events involved in endothelial dysfunction such as impaired vasorelaxation, eNOS uncoupling, leukocyte adhesion, endothelial senescence, and endothelial mesenchymal transition. The endothelial protective effects of RSV are found to be mediated by numerous molecular targets (e.g. Silent Information Regulator 1 (SIRT1), 5′ AMP-activated protein kinase (AMPK), endothelial nitric oxide synthase (eNOS), nuclear factor-erythroid-derived 2-related factor-2 (Nrf2), peroxisome proliferator-activated receptor (PPAR), Krüppel-like factor-2 (KLF2), and nuclear factor kappa-light-chain-enhancer of activated B cells (NF-kB)). Herein, we present an updated review addressing pharmacological effects and molecular targets of RSV in maintaining endothelial function, and the potential of this phytochemical for endothelial dysfunction-associated disorders.

Original languageEnglish
Article number105725
JournalPharmacological Research
Publication statusPublished - Aug 2021


Dive into the research topics of 'Resveratrol and endothelial function: A literature review'. Together they form a unique fingerprint.

Cite this